Advertisement
Screener

Cartesian Therapeutics, Inc. (RNAC) Form D

Cartesian Therapeutics, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2020-08-18: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-07-31; Total offering amount $25,000,000.
  • 2019-09-04: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-08-20; Total offering amount $5,752,495.
  • 2016-12-14: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-12-02; Total offering amount $4,999,984.
  • 2014-08-28: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2014-08-14; Total offering amount $4,450,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2020-08-18Rule 506(b)Equity2020-07-31$25,000,000$25,000,000$01
2019-09-04Rule 506(b)Equity2019-08-20$5,752,495$5,752,495$010
2016-12-14Rule 506(b)Equity2016-12-02$4,999,984$4,999,984$01
2014-08-28Rule 506(b)Equity2014-08-14$4,450,000$4,450,000$011
2014-07-15Rule 506(b)Equity2014-07-15$6,000,000$6,000,000$02
2014-04-09Rule 506(b)Equity2014-04-07$9,999,994$5,292,702$4,707,29211
2011-11-17Rule 506Equity2011-11-07$26,000,000$3,500,000$22,500,0001
2011-11-17Rule 506Equity2011-11-07$22,000,000$22,000,000$016
2010-04-06Rule 506Equity2010-03-22$15,000,006$15,000,006$014

Similar stocks

Stock NameCountryMarket CapPE Ratio
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23